-
No easy answers: European research consortia take on major challenges
COPENHAGEN, Denmark, July 10, 2026 (GLOBE NEWSWIRE) — Nine new Challenge Programme grants from the Novo Nordisk Foundation will support ambitious research across fungal diseases, cardiometabolic disease, soil health and non-equilibrium biological systems. With a European expansion, the 2026 awards unite strong research groups and diverse expertise across Europe in the pursuit of novel knowledge…
-
New Crypto: BNB Based AlphaPepe Nears Tier-1 Exchange Debut While Ethereum Price Prediction Targets $4000
MONACO, July 09, 2026 (GLOBE NEWSWIRE) — AlphaPepe is quickly becoming one of the new crypto names retail buyers are watching before the next public-market breakout. The BNB-based presale has now raised $1.95 million, crossed 10,000+ holders, and moved to a current price of $0.02095 while its presale window is closing soon. The timing is…
-
NTG Nordic Transport Group A/S – H1 2026 Conference Call
July 09, 2026 04:00 ET | Source: NTG Nordic Transport Group A/S NTG Nordic Transport Group A/S – H1 2026 Conference Call We expect to release the H1 2026 interim results of NTG Nordic Transport Group on the evening of August 10, 2026. A webcast and conference call will be held in the morning of…
-
Y-H2O Shines at Monaco Energy Boat Challenge, Enters Final Tuning on July
MONACO and SHENZHEN, China, July 09, 2026 (GLOBE NEWSWIRE) — The 13th Monaco Energy Boat Challenge officially kicked off with its Opening Ceremony on July 7. Shenzhen-based innovator Y-H2O, the only fully-fledged Chinese boat team, made a striking debut with its ‘Alaqua’ Y-3 model, drawing immediate and widespread attention, representing the Greater Bay Area to…
-
BiomX Signs Non-Binding Letter of Intent to Acquire Control of Revenue-Generating Security Infrastructure and Systems Integration Company, Expanding Its Security Platform with Critical Infrastructure and Secure-Site Integration Capabilities
Proposed acquisition of an Israeli company with approximately 20 years of operating experience is expected to strengthen BiomX’s Detection-Analysis-Response strategy through security systems, fire detection, access control, intrusion detection, building-control, electrical infrastructure and secure-site integration capabilities July 08, 2026 07:05 ET | Source: BiomX NETANYA, Israel, July 08, 2026 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE…
-
UK businesses drastically overestimate their AI progress
EXL’s 2026 UK Enterprise AI Study finds that while most companies think they’re ahead of the competition at AI, few actually see results at scale July 08, 2026 05:03 ET | Source: EXL 75% of companies believe they are ahead of their competitors on AI, but just 12% meet the criteria to qualify as an…
-
Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer’s Disease Research
July 07, 2026 09:12 ET | Source: Alamar Biosciences, Inc. eMTBR-Tau offers a non-invasive, blood-based measurement of the tau tangle burden, the core pathology associated with disease progression and cognitive decline in Alzheimer’s disease Immunoassay for eMTBR-Tau is available in the NULISAseq™ Neuro 220 panel and as a single-plex assay through the Technology Access Program…
-
Scality and WEKA deepen partnership to accelerate enterprise AI adoption
SAN FRANCISCO, July 07, 2026 (GLOBE NEWSWIRE) — Scality, a global leader in data infrastructure software for the AI era, and WEKA, the data and memory infrastructure company, today announced an expanded partnership in France, anchored by a new joint customer support agreement. Under the agreement, Scality will distribute the companies’ joint solution to customers…
-
Zealand Pharma – Transactions related to share buy-back program (week 27, 2026)
Company announcement No. 31 / 2026 Zealand Pharma – Transactions related to share buy-back program (week 27, 2026) Copenhagen, Denmark, July 6, 2026 – Zealand Pharma A/S (“the Company” or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, today reports transactions related to its share buy-back program (the…
-
JASIWAY Best-Selling Modern Sleeper Sofa Chair Launches on Wayfair, Bringing Flexible Small-Space Living to Modern American Homes
Sheridan, WY, July 04, 2026 (GLOBE NEWSWIRE) — JASIWAY, a modern furniture brand focused on flexible whole-home living solutions, announced that its best-selling Modern Sleeper Sofa Chair is now available on Wayfair, giving American consumers broader access to a compact, convertible furniture solution designed for today’s small-space homes, apartments, guest rooms, and hybrid living environments.…
-
Appili Therapeutics Announces Receipt from NIAID of a Notice of Termination for Convenience on the Contract for the VXV-01 Program
HALIFAX, Nova Scotia, July 03, 2026 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases today announced that it has received a Notice of Termination for Convenience from the National Institute of Allergy and Infectious Diseases (“NIAID”), part of the…
-
Alarum Technologies Announces Temporary Operational Pause of Certain Network Services
July 04, 2026 13:09 ET | Source: Alarum Technologies Ltd. Tel Aviv, Israel, July 04, 2026 (GLOBE NEWSWIRE) — Alarum Technologies Ltd. (Nasdaq: ALAR, TASE: ALAR) (“Alarum” or the “Company”) today announced the following update. Further to the Company’s announcements dated July 2 and July 3, 2026, the Company continues to investigate the recent incident…
-
Mark Leeds, D.O. PA Launches FloridaTaper.com, a Free Educational Resource on Benzodiazepine Tapering, Withdrawal, and BIND
The new website from Mark Leeds, D.O. PA offers more than 60 physician-written articles, with new articles published daily, for patients, families, and clinicians navigating slow benzodiazepine dose reductions. July 03, 2026 18:58 ET | Source: Mark Leeds, DO PA Fort Lauderdale, FL, July 03, 2026 (GLOBE NEWSWIRE) — Mark Leeds, D.O. PA, a Florida…
-
Hostinger Introduces Coupon Code for First Time Users to Get 20% Off via HostVerify.co
July 03, 2026 15:58 ET | Source: HostVerify San Francisco, CA, July 03, 2026 (GLOBE NEWSWIRE) — Hostinger remains a premier choice for launching and managing websites globally. To help users minimize setup expenses, HostVerify.co has partnered with Hostinger to offer an exclusive 20% discount for first time users. When accessing Hostinger through the verified…
-
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08
July 03, 2026 16:30 ET | Source: Teladoc Health, Inc. NEW YORK, July 03, 2026 (GLOBE NEWSWIRE) — Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee. Effective July 1, 2026, in connection with commencing employment as Head of Product of…
-
KTC Introduces H27E6, a 27-Inch WQHD 300Hz Monitor Built for Esports, Streaming, Creation, and Productivity
Houston, Texas, July 02, 2026 (GLOBE NEWSWIRE) — KTC, a professional display brand serving global gaming, creative, and productivity users, has introduced the KTC H27E6, a 27-inch WQHD Fast IPS monitor designed to meet the rising demand for high-refresh, multi-functional displays. Featuring a native 300Hz refresh rate, overclocking support up to 320Hz, professional-grade color accuracy,…
-
Jelly Force Male Enhancement Gummies Release Latest Formula for Men: JellyForce Unique Ingredient Profile Report
Pinellas Park, FL, July 02, 2026 (GLOBE NEWSWIRE) — These statements have not been evaluated by the Food and Drug Administration. JellyForce is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use, especially if currently taking prescription medications. JellyForce is a gummy dietary supplement formulated for men,…
-
Anoto Proposes New Corporate Identity as INQ Group AB
July 02, 2026 02:05 ET | Source: Anoto Group AB Anoto Group AB (publ) today announced that the Board of Directors will ask shareholders at the Company’s Annual General Meeting to approve changing the Company’s name to INQ Group AB (publ), reflecting its strategic transformation and aligning the listed company with its future-facing INQ brand. The…
-
GNI Group Completes Acquisition of AYUMI Pharmaceutical
TOKYO, July 01, 2026 (GLOBE NEWSWIRE) — GNI Group Ltd. (TSE: 2160, “GNI Group” or the “Company”) today announced that it has completed the acquisition of all shares of Ayumi Pharmaceutical Holdings Co., Ltd. from shareholders led by Blackstone. As a result, Ayumi Pharmaceutical Holdings Co., Ltd. and its subsidiary, Ayumi Pharmaceutical Co., Ltd. (“Ayumi…
-
Mesoblast Receives BLA Filing Number and Requests Modular Review for Rexlemestrocel-L in Patients with End-Stage Heart Failure and LVADs
June 30, 2026 20:38 ET | Source: Mesoblast Limited NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has received a Biologics License Application (BLA) filing number from the U.S. Food and Drug Administration (FDA) and has requested a…
-
POET Technologies Recaps Highlights of CEO’s Update on Commercial Activities and Provides Results of 2026 AGM
TORONTO, June 30, 2026 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (NASDAQ: POET), the designer and developer of Photonic Integrated Circuits (PICs), light sources and optical modules for the AI and data center markets, today reported the voting results of its Annual General Meeting (the “AGM”), which was held virtually on Friday,…
-
Press Release: Sanofi’s Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study
Sanofi’s Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study Nexviazyme met its primary endpoint, participants alive and free of invasive ventilation, in treatment-naïve infants zero to six months of age in the Baby-COMET phase 3 study Sanofi intends to submit the data to support a regulatory application in the…
-
SVT Robotics Surpasses Four Billion Transactions on its SOFTBOT Platform
NORFOLK, Va., June 29, 2026 (GLOBE NEWSWIRE) — SVT Robotics, a leader in interoperability software that provides the data foundation for enterprise and physical AI, today announced that its SOFTBOT Platform has surpassed four billion transactions, underscoring the scale, resilience, and performance of the infrastructure it delivers worldwide. With transaction volumes now totaling 100 million…
-
Zambon and Amneal Announce Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations
Positive CHMP opinion is based on data from the Phase 3 RISE-PD trial, which demonstrated significantly more “Good ON” time with fewer daily doses compared with immediate-release levodopa/carbidopa Hopledo® is already approved and marketed in the United States as CREXONT®, providing established regulatory and commercial experience as the therapy advances toward European approval More than…
-
AiraBreeze Announces Entry into the Portable Cooling Products Industry with Introduction of Its First Consumer Cooling Solution
London, UK, June 28, 2026 (GLOBE NEWSWIRE) — AiraBreeze today announced its entry into the portable cooling products industry through the introduction of its first consumer cooling solution following the completion of its initial product development phase. The announcement marks the company’s transition from product design and development into commercial operations as it begins offering…
-
TBoostExperts.com Announces Availability of 2026 Consumer Report on Testosterone Booster Supplements and Men’s Health Supplement Evaluation
NEW YORK,USA, June 27, 2026 (GLOBE NEWSWIRE) — TBoostExperts.com today announced the availability of its 2026 Consumer Research Report on testosterone booster supplements and men’s health supplement evaluation, a newly published educational resource developed to help adult consumers better understand how to review supplement labels, ingredient disclosures, dosage transparency, product claims, and company information before…
-
HDFC ERGO Highlights the Importance of Comprehensive Car Insurance for Today’s Vehicle Owners
Mumbai, Maharashtra, June 27, 2026 (GLOBE NEWSWIRE) — Today’s vehicle owners face rising repair costs, accident risks, theft concerns, and unpredictable weather conditions that can lead to major financial stress. HDFC ERGO highlights the need for wider vehicle protection as owners look beyond basic compliance and focus on financial preparedness. While considering car insurance renewal online,…
-
Appili Therapeutics Reports Fiscal Year 2026 Financial and Operational Results
LIKMEZ® (ATI-1501) commercial momentum building in U.S. market US$40 million NIAID award supporting VXV-01 advancement through Phase 1 HALIFAX, Nova Scotia, June 26, 2026 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced its financial and…
-
PrivacyHawk Launches Enterprise Service to Reduce Shadow Digital Footprint and Third-Party Breach Risk
LOS ANGELES, June 26, 2026 (GLOBE NEWSWIRE) — PrivacyHawk, the transparency-first data privacy company, today announced the general availability of PrivacyHawk Enterprise — a first-of-its-kind solution that identifies and eliminates the shadow IT accounts, abandoned SaaS subscriptions, and forgotten third-party services quietly exposing organizations to breach risk. Every organization has an invisible attack surface. Shadow…
-
Thought Leadership & Innovation Foundation Founder Bill Oldham Launches New Book: Beyond Better Data: What Actually Changes Health Care?
MCLEAN, Va., June 26, 2026 (GLOBE NEWSWIRE) — The Thought Leadership & Innovation Foundation (TLI) proudly announces the release of Beyond Better Data: What Actually Changes Health Care? a new book by Founder and Chairman Bill Oldham that brings together decades of experience in innovation, leadership, healthcare transformation, and the practical application of emerging technologies to…
-
Shoals Technologies Group Secures ITC Victory Upholding American Intellectual Property
PORTLAND, Tenn., June 25, 2026 (GLOBE NEWSWIRE) — Shoals Technologies Group, Inc. (“Shoals”) (Nasdaq: SHLS), a global leader in electrical infrastructure solutions for the energy transition market, announced a decisive victory in its patent infringement action against Voltage, LLC (“Voltage”) after the U.S. International Trade Commission affirmed the Administrative Law Judge’s (ALJ) ruling. The decision…
-
Commure Named “Overall NLP Company of the Year” in 2026 AI Breakthrough Awards
MOUNTAIN VIEW, Calif., June 25, 2026 (GLOBE NEWSWIRE) — Commure, a leading healthcare technology company, today announced it has been named “Overall NLP Company of the Year” in the 2026 AI Breakthrough Awards. The annual awards program recognizes the world’s most innovative companies, technologies, and products in artificial intelligence. Selected from more than 5,000 nominations…
-
Caseware Netherlands Launches Financial Reporting Visualization Agent Powered by Verity
APELDOORN, The Netherlands, June 25, 2026 (GLOBE NEWSWIRE) — Caseware, the leading AI platform for assurance and financial reporting, today announced it will launch its Financial Reporting Visualization Agent for the Netherlands market. The new AI-powered capability enables accounting and audit professionals to generate auditable financial charts and visualizations directly within Caseware engagements using natural…
-
The Developing Doctor Launches CME-Accredited Course to Enhance Physician Wellbeing
Iowa City, IOWA, June 24, 2026 (GLOBE NEWSWIRE) — The Developing Doctor has unveiled its latest self-paced course, “Mastery & Wellness: How to Thrive as a Physician,” now approved for 12 physician CME credits. This course is jointly provided with the Postgraduate Institute for Medicine (PIM), making it eligible for reimbursement through most institutional CME…
-
BNO Developments Makes Energy Class A Its Default Standard for Shortlisted Cyprus New-Builds
June 24, 2026 05:03 ET | Source: BNO Developments LIMASSOL, Cyprus, June 24, 2026 (GLOBE NEWSWIRE) — As energy efficiency shifts from a selling point to a resale necessity, the Cyprus specialist is building the standard into every shortlist it sends. BNO Developments announced that Energy Class A-rated properties will become the default standard for…
-
Coherus and Zumutor Biologics Announce Clinical Collaboration to Evaluate ZM008 in Combination with LOQTORZI® (toripalimab-tpzi)
– First patient dosed in a Phase 1 study evaluating ZM008, an anti-LLT1 mAb, in combination with LOQTORZI, a next-generation PD-1 inhibitor – June 23, 2026 14:00 ET | Source: Coherus Oncology, Inc. REDWOOD CITY, Calif., June 23, 2026 (GLOBE NEWSWIRE) — Coherus Oncology, Inc. (Nasdaq: CHRS) and Zumutor Biologics Inc. (“Zumutor”), an immuno-oncology biotech…
-
Regula Helps Uber Build a Nationwide Driver Verification Network in Poland
RESTON, Va., June 23, 2026 (GLOBE NEWSWIRE) — Regula is helping Uber bring advanced driver verification technologies to more cities across Poland. By expanding the use of Regula’s document authentication solutions nationwide, Uber is strengthening fraud prevention and adding an extra layer of high-assurance identity checks that goes beyond standard industry practices. As part of…
-
Dyne Therapeutics Appoints Barry Greene to Board of Directors
June 22, 2026 16:10 ET | Source: Dyne Therapeutics, Inc. WALTHAM, Mass., June 22, 2026 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced the appointment of Barry Greene to its Board of Directors. Mr. Greene brings more…
-
Eva Live Targets Cybersecurity Aggressively, Standing Up an Internal Task Force to Meet AI Industry Needs
Through its Eva Defense subsidiary, Eva Live is forming a dedicated internal cybersecurity task force to move hard and fast on acquisitions and partnerships LAS VEGAS, NV, June 22, 2026 (GLOBE NEWSWIRE) — Eva Live Inc. (NASDAQ: GOAI) (“Eva Live” or the “Company”), a technology company focused on artificial intelligence and digital innovation, today announced…
-
MoonLake Announces Week 52 Results of Sonelokimab from its Phase 3 VELA Program in Hidradenitis Suppurativa and Confirms Investor Day on June 22, 2026
Results from the Phase 3 VELA clinical trials at Week 52 in adults with moderate-to-severe hidradenitis suppurativa (HS) demonstrate sonelokimab’s (SLK) potential best-in-class and best-in-disease profile, with consistent responses that are higher than those observed in trials of competing agents at the end of their respective parental trials Namely, ~67% of patients treated with SLK…
-
Global Nexa Initiative Launches to Support Climate and Health Innovations
Global consortium seeks bold, scalable solutions that reduce climate-driven health harms on vulnerable communities June 21, 2026 13:30 ET | Source: Grand Challenges Canada LONDON, June 21, 2026 (GLOBE NEWSWIRE) — At London Climate Action Week, Grand Challenges Canada (GCC) and the Science for Africa Foundation (SFA Foundation) today announced the launch of Nexa, a global initiative to support locally led innovations that address the growing health impacts of…
-
JellyFil Publishes Updated 2026 Product Information for Its Premium Gummy Dietary Supplement, Including Full Ingredient List, Pricing, Refund Policy, and Customer Service Details
Largo, FL, June 20, 2026 (GLOBE NEWSWIRE) — These statements have not been evaluated by the U.S. Food and Drug Administration. JellyFil is not intended to diagnose, treat, cure, or prevent any disease. Consumers should consult a qualified healthcare professional before using any dietary supplement, particularly if currently taking prescription medications or managing existing health…
-
GARVEE Teams Up with TikTok Shop for Super Brand Day, Bringing Exclusive Limited-Time Deals Across Summer Cooling, Outdoor Living and Best-Selling Home Essentials
ONTARIO, Calif., June 20, 2026 (GLOBE NEWSWIRE) — GARVEE has announced its participation in TikTok Shop Super Brand Day from June 18 to July 2, 2026. During this limited-time shopping event, shoppers can explore a curated selection of summer cooling products, outdoor summer lifestyle essentials and top-performing TikTok Shop bestsellers through GARVEE’s official TikTok Shop…
-
BreathEaseX Publishes Updated 2026 Product Information for Its Oral Spray Dietary Supplement, Including Full Ingredient List, Pricing, Refund Policy, and Customer Service Details
AURORA, CO, June 19, 2026 (GLOBE NEWSWIRE) — These statements have not been evaluated by the U.S. Food and Drug Administration. BreathEaseX is not intended to diagnose, treat, cure, or prevent any disease. Consumers should consult a qualified healthcare professional before using any dietary supplement, particularly if currently taking prescription medications or managing existing health…
-
Altius Inspiro Secures Second Consecutive Fortress Cybersecurity Award for Network Security Excellence
MANILA, Philippines, June 20, 2026 (GLOBE NEWSWIRE) — Altius Inspiro, a global leader in digital customer experience (CX) and business process services (BPS), today announced it has won the prestigious 2026 Fortress Cybersecurity Award in the Network Security category from the Business Intelligence Group. Earning this distinction for the second consecutive year, the award highlights…
-
Desert Hope Treatment Center Launches First Responder Lifeline Program, Offering Confidential Care for Frontline Heroes
LAS VEGAS, June 18, 2026 (GLOBE NEWSWIRE) — Desert Hope Treatment Center, a leading addiction treatment center in Las Vegas, has introduced its First Responder Lifeline Program, designed specifically for law enforcement officers, firefighters, EMTs, dispatchers, corrections officers, and other public safety professionals. The program was developed in collaboration with public safety leaders, including representatives…
-
OVIOS Launches Fire Pit Conversation Collection Ahead of Father’s Day
LOS ANGELES, CA, June 18, 2026 (GLOBE NEWSWIRE) — As Father’s Day approaches, OVIOS has launched its Fire Pit Conversation Collection, a new outdoor furniture collection designed to help families create more comfortable, inviting, and experience-centered backyard spaces for celebrating dads. The launch comes as more American families are rethinking traditional Father’s Day gifting. Instead…
-
eimmigration Launches Heroes Spotlight to Recognize the Top Paralegals in Immigration Law
SAN DIEGO, June 17, 2026 (GLOBE NEWSWIRE) — eimmigration by Cerenade, the leading immigration case management software trusted by 17,000 legal professionals, today announced the launch of Heroes Spotlight: Top Paralegals in Immigration Law. The recognition program was unveiled at the American Immigration Lawyers Association (AILA) Annual Conference, where nominations officially opened. Nominations are open…
-
Nicox Announces Positive Pre-submission Regulatory Feedback in China Supporting NDA filing for NCX 470
Press Release Nicox Announces Positive Pre-submission Regulatory Feedback in China Supporting NDA filing for NCX 470 Exclusive licensee for China, Ocumension, received positive pre-submission regulatory feedback from the Chinese Center for Drug Evaluation (CDE) for NCX 470 Based on this feedback, Ocumension intends to proceed with the New Drug Application (NDA) submission in China Submission…
-
Atos joins CrowdStrike’s Project QuiltWorks to advance sovereign AI adoption and secure frontier AI risk
Press Release Atos joins CrowdStrike’s Project QuiltWorks to advance sovereign AI adoption and secure frontier AI risk Atos’ leadership at the intersection of cybersecurity, AI and digital sovereignty strengthens QuiltWorks’ ecosystem Paris, France – June 17, 2026 – Atos, a global leader of AI-powered digital transformation, today announces that it has joined CrowdStrike’s Project QuiltWorks.…
-
Resolution Therapeutics extends inflammatory and fibrotic disease pipeline with in vivo Regenerative Macrophage Therapy
Material Transfer Agreements provide access to leading lipid nanoparticle formulations to validate delivery of its proprietary payloads and accelerate development of in vivo Regenerative Macrophage Therapy Development programme complements Company’s autologous engineered Regenerative Macrophage Therapy, RTX001, in Ph 1/2 clinical development Together, programmes aim to broaden patient population able to benefit from Regenerative Macrophage Therapy…
-
Bond Announces Conversion of Outstanding Debt into Equity at Significant Premium to Market
June 16, 2026 08:07 ET | Source: Our Bond, Inc. Major Investor Exchanges Approximately $3.3 Million of Debt for Convertible Preferred Equity Priced at $2.0265 Per Common Share — a Premium of More Than 200% to Recent Trading Levels Above-Market Conversion Along With Separate Payment Schedule Adjustment Reduce 2026 Debt Burden By $4.3M, Reflecting Investors’…
-
Weston Family Foundation invests an additional $37 million to safeguard one of Canada’s most ecologically valuable and threatened ecosystems
The conservation initiative brings together Indigenous communities, ranchers, and conservation organizations to protect Canada’s critical prairie grasslands June 16, 2026 06:00 ET | Source: Weston Family Foundation TORONTO, June 16, 2026 (GLOBE NEWSWIRE) — The Weston Family Foundation just announced an additional $37 million in funding through the Weston Family Prairie Grasslands Initiative, strengthening and…
-
SoftServe Cuts AI Agent Deployment from Months to Four Weeks
New platform helps companies move AI agents out of test projects and into live operations, without building custom tools from scratch June 15, 2026 10:33 ET | Source: SoftServe, Inc AUSTIN, Texas, June 15, 2026 (GLOBE NEWSWIRE) — SoftServe, a digital engineering and technology services company, today released the SoftServe Agent Management Platform. It gives…
-
Polyrizon Advances NASARIX™ Development with Key Human Study to Characterize Nasal Residence Time and Support FDA Regulatory Pathway
June 15, 2026 08:05 ET | Source: Polyrizon Ltd. New performance and characterization study in collaboration with leading European medical center marks a critical milestone in the validation of the NASARIX™ allergy blocker’s protective barrier function Raanana, Israel, June 15, 2026 (GLOBE NEWSWIRE) — Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech…
-
Orbs Launches On-Chain Execution Infrastructure for Institutional Crypto Trading
TEL AVIV, Israel, June 14, 2026 (GLOBE NEWSWIRE) — Orbs, the decentralized Layer-3 blockchain infrastructure focused on advanced on-chain trading, today announced Orbs Institutional, a new offering that provides trading desks, OTC firms, treasuries, custodians and financial platforms with direct access to its on-chain execution infrastructure. The launch builds on technology that has processed more…
-
Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026
– Verekitug, administered once every three months, led to clinically meaningful improvements in nasal polyp score (NPS) in approximately 80% of participants – – Majority of verekitug-treated participants experienced clinically meaningful improvements across key secondary endpoints, including 72% in nasal congestion and 83% in CRSwNP total symptom score – WALTHAM, Mass., June 14, 2026 (GLOBE…
-
Rocket Doctor Grants Stock Options and RSUs
June 12, 2026 17:13 ET | Source: Rocket Doctor AI Inc. Vancouver, BC, June 12, 2026 (GLOBE NEWSWIRE) — Rocket Doctor AI Inc. ( CSE: AIDR , OTC: AIRDF , Frankfurt: 939 ) (“Rocket Doctor AI”) has granted an aggregate 47,013 stock options, exercisable at $0.71 per share and valid for a term of three…
-
Exploratory Efficacy Data Suggests Further Study of Peanut Tolerance with Oral Mucosal Immunotherapy (OMIT)
NEW YORK, June 12, 2026 (GLOBE NEWSWIRE) — Intrommune Therapeutics, Inc., a clinical-stage biotechnology company committed to developing a patient-friendly treatment platform for people with peanut and other food allergies, today announced the presentation of exploratory efficacy data from the Oral Mucosal Escalation Goal Assessment (OMEGA) Phase 1 safety trial at the 2026 Eastern Allergy…
-
Nissan AMIEO Completes 180-Market Pricing Transformation with Syncron, Ahead of Schedule
STOCKHOLM, Sweden, June 11, 2026 (GLOBE NEWSWIRE) — Syncron, a global leader in intelligent aftermarket solutions, today announced that Nissan Africa, Middle East, India, Europe, & Oceania (AMIEO) has completed a full rollout of its parts pricing solution across 40 primary markets and more than 140 export markets, finishing ahead of schedule in Q1 2026…
-
Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, June 10, 2026 (GLOBE NEWSWIRE) — NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), announced today that its shareholders voted in favour of all items of business brought before them at the Company’s annual and…
-
Patton Awarded Subcontract to Develop Source-Secure Fiber Optic Modules for U.S. Defense Applications
“This award reflects the growing importance of trusted, domestic supply chains in national security systems.” Bryan DuboisV.P. Special ProjectsPATTON GAITHERSBURG, Md., June 10, 2026 (GLOBE NEWSWIRE) — Patton®—a US-based electronics developer and provider of contract engineering and manufacturing services—today announced it has been awarded a subcontract to develop specialized, source-secure fiber optic transport modules in…
-
ARCPOINT ANNOUNCES APPOINTMENT OF PETER KENDALL AS INTERIM CHIEF EXECUTIVE OFFICER
June 09, 2026 19:00 ET | Source: ARCpoint Inc. GREENVILLE, South Carolina, June 09, 2026 (GLOBE NEWSWIRE) — ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) announces that its Board of Directors has appointed Peter Kendall as Interim Chief Executive Officer of the Company, effective June 9, 2026. Mr. Kendall’s appointment remains subject to acceptance…
-
Bond Highlights Growing Recognition of its Preventative Personal Security for Both Employees and Families
June 09, 2026 08:07 ET | Source: Our Bond, Inc. Series of Opinion Pieces by Bond CEO Doron Kempel Across Consumer and Business Media Reflect a Shift from Reactive Emergency Response to 24/7 Preventative Personal Security Bond’s Platform Has Supported More Than 1.4 Million Security Service Requests, Including Over 10,000 Emergencies and Life-Saving Interventions NEW…
-
GNI Group to Acquire Ayumi Pharmaceutical Holdings, Expanding Its Position as a Global Biopharmaceutical Company
Transaction Establishes a Large-Scale Pharmaceutical Platform in Japan and Strengthens Commercial Capabilities Across Key Therapeutic Areas June 07, 2026 19:41 ET | Source: GNI Group Co., Ltd. TOKYO, June 07, 2026 (GLOBE NEWSWIRE) — GNI Group Co., Ltd. (TSE: 2160) today announced that it has entered into an agreement to acquire 100% of the shares…
-
LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China
The New Drug Application for LNZ100 in China was submitted September 2025 with approval anticipated in Q1 2027 June 07, 2026 19:30 ET | Source: LENZ Therapeutics, Inc. SAN DIEGO, June 07, 2026 (GLOBE NEWSWIRE) — LENZ Therapeutics, Inc. (Nasdaq: LENZ, “LENZ” or the “Company”), a pharmaceutical company focused on the commercialization of VIZZ® (aceclidine…
-
Astrall Dynamics Makes INTERSCHUTZ 2026 Debut with Hypertron-T01 Quadruped Firefighting Robot
HANOVER, Germany, June 07, 2026 (GLOBE NEWSWIRE) — Astrall Dynamics demonstrated its Hypertron-T01 heavy-duty quadruped robot at INTERSCHUTZ 2026, demonstrating a complete, unmanned firefighting solution designed to support firefighters by performing high-risk tasks in hazardous zones. In active fireground scenarios, traditional robotic systems often force a critical operational trade-off: high mobility with limited payload, or…
-
Astrall Dynamics Showcases Unmanned Quadruped Firefighting Robot at INTERSCHUTZ 2026
HANOVER, Germany, June 07, 2026 (GLOBE NEWSWIRE) — Astrall Dynamics at INTERSCHUTZ 2026’s debut demonstrated its Hypertron-T01 heavy-duty quadruped robot. Positioned as a complete, unmanned firefighting solution, the system featured a live demo designed to support firefighters by performing high-risk tasks in hazardous zones. Traditional firefighting robots force an operational trade-off: high mobility with limited…
-
Her Bodhi Claims Evaluated: What Research Reveals About This Primal Queen Alternative, Weight Loss Support and Consumer Reviews
Editorial note: This article is an independent informational evaluation of publicly available product information. It is not medical advice, not a diagnosis or treatment recommendation, and not an endorsement of any brand. Dietary supplements are not medical devices and are not intended to diagnose, treat, cure, or prevent any disease, including menopause. Statements have not…
-
SlimTide Capsules [UPDATED WARNING 2026] Slim Tide Uncovering the Real Truth Behind the Trending Weight Loss Supplement
Largo, FL, June 06, 2026 (GLOBE NEWSWIRE) — SlimTide is a ketogenic support supplement created to help individuals pursuing weight-management goals through nutritional ketosis. The formula features a specialized blend of exogenous ketones designed to complement a low-carbohydrate lifestyle and support metabolic efficiency. SlimTide: A Complete Consumer Guide As obesity rates and lifestyle-related health concerns…
-
Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
June 05, 2026 20:13 ET | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up to approximately $15.2 million of potential additional gross proceeds upon the exercise in full of warrants Net proceeds anticipated to extend cash runway into first quarter of 2027, beyond expected FDA submission; if warrants are exercised in full for cash,…
-
All-Round for Work & Play: KTC Dual-Mode Monitor H27P6 Adapts to Full-Scenario Needs
Houston, Texas, USA, June 05, 2026 (GLOBE NEWSWIRE) — I. Hybrid Work Fuels Rising Multi-Monitor Demand The growing prevalence of hybrid work is reshaping global professionals’ work and leisure habits. Recent research indicates remote work has driven a 28% uptick in multi-monitor adoption among U.S. knowledge workers; WFH users see the same 28% year-on-year rise…
-
NatureU® Now Has Three Clinical Studies Publicly Registered on ClinicalTrials.gov as 56-Day PQQ Skin-Aging Study (NCT07571629) Joins Two Previously Published Peer-Reviewed Trials
Kwun Tong, Kowloon, HK, June 05, 2026 (GLOBE NEWSWIRE) — The newly registered 56-day exploratory study of NatureU® Mind Care BeautyU Caps — reporting within-participant changes of −46.7% in crow’s-feet wrinkle count and +58.7% in stratum corneum hydration at Day 56 — joins NatureU’s prior sleep and satiety clinical trials, both already published in peer-reviewed…
-
Fangzhou Showcases AI-Powered Chronic Disease Management Solution With Tencent Health at Tencent Cloud Conference
BEIJING, June 05, 2026 (GLOBE NEWSWIRE) — Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, attended the 2026 Tencent Cloud AI Industry Applications Summit in Beijing, where it showcased its “AI + Chronic Disease Services” digital solution developed in collaboration with Tencent Health. The conference, themed “Agent…
-
Chiesi Global Rare Diseases Announces European Commission Approval of LOJUXTA® (lomitapide) ▼ Capsules for Paediatric Use in Homozygous Familial Hypercholesterolaemia (HoFH)
European Commission approval expands the indication of lomitapide in the European Union (EU) to include children 5 years of age and older with HoFH, an ultra-rare genetic disorder affecting LDL-cholesterol levels June 05, 2026 02:00 ET | Source: Chiesi Global Rare Diseases PARMA, Italy, June 05, 2026 (GLOBE NEWSWIRE) — Chiesi Global Rare Diseases, a…
-
Crypto Market News: AlphaPepe To Announce First CEX Partnership as XRP Price Prediction Hits $8.00
MONACO, June 04, 2026 (GLOBE NEWSWIRE) — Crypto market news is turning toward AlphaPepe after the project confirmed that its first centralized exchange partnership reveal is now expected within weeks. The presale has crossed $1.46 million in total capital raised, Stage 17 is live at $0.01858, and holder growth has climbed past 9,200 while AlphaSwap…
-
Impact Analytics Releases “The Retail Demand Reset” Report, Warning of $5B+ Annual Capital Exposure as GLP-1 Adoption Reshapes Apparel Economics Across Sizing and Assortment
NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) — Impact Analytics today announced the release of their latest research report, The Retail Demand Reset: How GLP-1 Adoption Is Reshaping Apparel Economics, From Size Curves to Assortment Architecture, Capital Allocation, and Sustainability Risk. Report findings were featured in the Wall Street Journal. Building on the company’s 2024 and…
-
Press Release: Sanofi launches 2026 global employee stock purchase plan
Sanofi launches 2026 global employee stock purchase plan Paris, June 4, 2026. Sanofi’s global employee shareholder plan, Action 2026, opens on June 9, 2026, to around 75,000 employees in 52 countries. Now in its 12th year, the program demonstrates the ongoing commitment of Sanofi and its Board of Directors to involve employees in the company’s…
-
Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi® and Simponi Aria®, and AVT06, a proposed biosimilar to Eylea®
REYKJAVIK, Iceland, June 4, 2026 – Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the resubmission to the U.S. Food and Drug Administration (FDA) of Biologics License Applications (BLAs) for AVT05, a proposed biosimilar to Simponi® and Simponi Aria® (golimumab), and AVT06,…
-
Sword Group: Strategic contract with eu-LISA
Sword Group | eu-LISA framework contract awarded to leading consortium Sword ranked first in a €93 million contract for the EU Entry/Exit System Sword Services Greece, leading a consortium alongside Netcompany and Sopra Steria, has been ranked first and awarded a contract under eu-LISA’s Dynamic Purchasing System for the development and maintenance of the Entry/Exit…
-
It’s Not a Prenatal Class, It’s a Social Club With a Curriculum for Parenthood — Launching in Miami This August
MIAMI, June 03, 2026 (GLOBE NEWSWIRE) — Miami has attracted transplants, globally mobile families, and ambitious young professionals who are building lives far from the support systems they grew up with. At the same time, lifelong Miami families are navigating parenthood in a city that can often feel fast-paced, disconnected, and isolating during one of…
-
Noah Medical Appoints Dr. Krish Bhadra as Chief Pulmonary Advisor
Pioneering Physician and Interventional Pulmonology Innovator Joins Noah Medical to Accelerate the Next Era of Robotic-Assisted Lung Cancer Diagnosis and Treatment June 03, 2026 08:00 ET | Source: Noah Medical SAN CARLOS, Calif., June 03, 2026 (GLOBE NEWSWIRE) — Noah Medical, a medical robotics company dedicated to earlier, more accurate lung cancer diagnosis, announced the…
-
Pure DC Demonstrates Gas Connected Data Centres can be Decarbonised at Operational Scale with Europe’s First Large-Scale Cross-Border Biomethane Deal
Pure DC’s Dublin site decarbonised with biomethane from Germany Transaction is a 9,000-fold increase on its 2025 Proof of Concept 9GWh of RED II & III-compliant biomethane balanced from Germany to Ireland and consistent with Ireland’s Large Energy User policy and Climate Action Plan LONDON, June 03, 2026 (GLOBE NEWSWIRE) — Pure Data Centres Group…
-
Francisco Ranzi Müller Leads the MicAi-X Technology Upgrade, Bringing Automated Trading Capabilities Into a New Cycle
SAN DIEGO, June 03, 2026 (GLOBE NEWSWIRE) — Recently, the automated trading program service platform MicAi-X has officially launched a new round of platform system upgrade plan. Founder and IT team leader Francisco Ranzi Müller will lead the relevant technical planning and system optimization efforts. This upgrade is regarded as a key milestone for MicAi-X…
-
Jersey College Offers Associate Degree for NJ Nursing Students With and Without Prior Licensure
Teterboro and Ewing campuses offer full ADN program. Next class starts August 17. June 02, 2026 10:05 ET | Source: Jersey College TETERBORO, N.J., June 02, 2026 (GLOBE NEWSWIRE) — Jersey College, the institution dedicated to excellence in nursing education, provides an Associate Degree in Nursing program at its Teterboro and Ewing, N.J., campuses, offering…
-
MAPS Publishes First-of-Its-Kind Literature Review on Psychedelic Healing for People Impacted by the Criminal Legal System
“Relocating the Root” is a scoping literature review on the mental health needs of people directly impacted by the criminal legal system Publishing this literature review launches a project that builds on nearly four decades of MAPS advocacy by turning the lens of psychedelic research toward people directly harmed by the war on drugs MAPS…
-
Gaxos Secures Additional Funding from Amazon AWS to Accelerate AI Sales Platform Development
June 02, 2026 08:12 ET | Source: GAXOS.AI INC. Roseland, NJ, June 02, 2026 (GLOBE NEWSWIRE) — Gaxos.ai Inc. (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various high-growth sectors, today announced that Amazon Web Services (“AWS”) has committed additional funding to accelerate Gaxos Labs’ AI-powered sales coaching platform. The additional AWS…
-
J-Star Holding Provides Additional Details on Baytown Economic Development Foundation LOI Supporting Proposed U.S. Solid-State Battery Manufacturing Facility
Formal LOI Details Site Selection Support, Infrastructure Requirements, 18-Month Site Availability Commitment, and Framework for Long-Term Facility Development June 01, 2026 11:50 ET | Source: J-Star Holding Co., Ltd TAICHUNG CITY, Taiwan, June 01, 2026 (GLOBE NEWSWIRE) — J-Star Holding Co., Ltd. (Nasdaq: YMAT) (“J-Star” or the “Company”), today provided additional details regarding the commitment…
-
Zealand Pharma – Transactions related to share buy-back program (week 22, 2026)
Company announcement No. 20 / 2026 Zealand Pharma – Transactions related to share buy-back program (week 22, 2026) Copenhagen, Denmark, June 1, 2026 – Zealand Pharma A/S (“the Company” or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, today reports transactions related to its share buy-back program (the…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.
